✦ LIBER ✦

Treatment of disseminated cancer by intravenous hydroxyurea and autogenous bone-marrow transplants: Experience with 35 patients

✍ Scribed by Dr. Irving M. Ariel

Publisher: John Wiley and Sons
Year: 1975
Tongue: English
Weight: 284 KB
Volume: 7
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.2930070502

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Massive doses of hydroxyurea (Hydrea) were given to 35 patients suffering from different cancers. Protection to the hematopoietic system was obtained by autogenous marrow transfusions.

The clinical response obtained was not considered superior to the results obtained by administering the drug orally over a prolonged period.

The described technique is safe and relatively atraumatic, and it may be advisable to administer a large priming dose by this technique to be followed by smaller maintenance doses of a given anticancer chemotherapeutic agent.

📜 SIMILAR VOLUMES

Treatment of disseminated melanoma by sy

Treatment of disseminated melanoma by systemic melphalan, methotrexate and autogenous bone marrow transplants. Experience with 114 patients

✍ Irving M. Ariel; George T. Pack 📂 Article 📅 1967 🏛 John Wiley and Sons 🌐 English ⚖ 685 KB

Impact of disseminated tumor cells in bo

Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy

✍ Arne Berg; Aasmund Berner; Wolfgang Lilleby; Øyvind S. Bruland; Sophie D. Fosså; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 290 KB 👁 2 views

## Abstract The purpose of this study was to explore whether detection of disseminated tumor cells (DTCs) in bone marrow (BM) of nonmetastatic prostate cancer (PC) was associated with other clinical or histopathological factors at diagnoses or clinical outcome subsequent to definitive radiotherapy